Related Experiment Video
Updated: Jun 20, 2026

12:23
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Diffuse white matter damage is absent in neuromyelitis optica.
F Aboul-Enein1, M Krssák, R Höftberger
1Department of Neurology, SMZ-Ost Donauspital, Vienna, Austria. fahmy.aboul-enein@chello.at
AJNR. American Journal of Neuroradiology
|September 15, 2009
Summary
Neuromyelitis optica (NMO) shows no diffuse white matter damage, unlike multiple sclerosis (MS). This study found normal-appearing white matter (NAWM) in NMO patients, suggesting it is distinct from MS.
Area of Science:
- Neuroimmunology
- Neuroimaging
- Metabolic Neuroscience
Background:
- Neuromyelitis optica (NMO) is a relapsing inflammatory condition affecting optic nerves and spinal cord.
- The distinction between NMO and multiple sclerosis (MS) remains unclear.
- Previous studies suggest normal-appearing white matter (NAWM) is affected in MS but not NMO.
Purpose of the Study:
- To investigate the metabolic characteristics of NAWM in patients with NMO.
- To determine if diffuse white matter damage is present in NMO.
- To differentiate NMO from MS based on NAWM integrity.
Main Methods:
- Prospective study of 8 NMO patients and 8 healthy controls.
- Proton magnetic resonance spectroscopy (¹H-MRSI) at 3T to measure metabolite ratios (NAA/Cr, Cho/Cr) and concentrations in NAWM.
- All NMO patients tested positive for NMO-immunoglobin G (NMO-IgG).
Main Results:
- No significant differences in the metabolic pattern of NAWM were observed between NMO patients and healthy controls.
- Key metabolite ratios and concentrations in NAWM were comparable between the groups.
Conclusions:
- Diffuse white matter damage is absent in patients with NMO.
- NMO appears to be a distinct entity from MS, characterized by the preservation of NAWM integrity.
- These findings support NMO as a separate disease entity.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
